EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Letter to the Editor

Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib

Gonçalo Nunes ¹ , Cristina Fonseca ¹ , Marta Patita ¹ , Mario João Aleixo ² , Miguel Ramalho ³ , Jorge Fonseca ^{1 4}

Author Affiliation(s)

1.

Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal

2.

Department of Infectiology, Hospital Garcia de Orta, Almada, Portugal

3.

Department of Radiology, Hospital Garcia de Orta, Almada, Portugal

4.

CiiEM, Center for Interdisciplinary Research Egas Moniz, Monte da Caparica, Portugal

Turk J Gastroenterol 2020; 31: 184-186

DOI: 10.5152/tjg.2020.181044

Read: 1450 Downloads: 703 Published: 04 March 2020

Volume 31, Issue 2, February 2020

Previous Article

Cite this article as: Nunes G, Fonseca C, Patita M, Aleixo MJ, Ramalho M, Fonseca J. Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib. Turk J Gastroenterol 2020; 31(2): 184-6.

Files